Karhunen–Loève Expansion–Based Residual Anomaly Map for Resource-Efficient Glioma MRI Segmentation

Anthony Joon Hur · 2026

Read Karhunen–Loève Expansion–Based Residual Anomaly Map for Resource-Efficient Glioma MRI Segmentation by Anthony Joon Hur (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2601-11833.txt.

Introduction

Anthony Joon Hur works on fast brain scan cuts for glioma, a type of brain tumour. Good cuts guide care and surgery. Deep learning gives the best cuts so far. Yet it needs big data sets or heavy machines, which many clinics lack. His method uses a Karhunen-Loève expansion to build a map of odd spots. That map flags parts that do not fit the norm. A light method could bring tumour cuts to small clinics.

Catalog record

CREATORAnthony Joon Hur
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE27 KB
VERSION1.0
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2601-11833

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Karhunen–Loève Expansion–Based Residual Anomaly Map for Resource-Efficient Glioma MRI Segmentation Anthony Joon Hur Abstract Accurate segmentation of brain tumors is essential for clinical diagnosis and treatment planning. Deep learning is currently the state-of-the-art for brain tumor segmentation, yet it requires either large datasets or extensive computational resources that are inaccessible in most areas. This makes the problem increasingly difficult: state-of-the-art models use thousands of training cases and vast computational power, where performance drops sharply when either is limited. The top performer in the Brats GLI 2023 competition relied on supercomputers trained on over 92,000 augmented MRI scans using an AMD EPYC 7402 CPU, six NVIDIA RTX 6000 GPUs (48GB VRAM each), and 1024GB of RAM over multiple weeks. To address this, the Karhunen–Loève Expansion (KLE) was implemented as a feature extraction step on downsampled, z-score normalized MRI volumes. Each 240 × \times 240 × \times 155 multi-modal scan is reduced to four 48 3 48^{3} channels and compressed into 32 KL coefficients. The resulting approximate reconstruction enables a residual-based anomaly map, which is upsampled and added as a fifth channel to a compact 3D U-Net. All experiments were run on a consumer workstation (AMD Ryzen 5 7600X CPU, RTX 4060Ti (8GB VRAM), and 64GB RAM) while using far fewer training cases. This model achieves post-processed Dice scores of 0.929 (WT), 0.856 (TC), and 0.821 (ET), with HD95 distances of 2.93, 6.78, and 10.35 voxels. These results are significantly better than the winning BraTS 2023 methodology for HD95 distances and WT dice scores. This demonstrates that a KLE-based residual anomaly map can dramatically reduce computational cost and data requirements while retaining state-of-the-art performance. 1 Background 1.1 Clinical Impact of Gliomas 1.1.1 Epidemiology and Clinical Impact Gliomas are the most common type of primary malignant brain tumor, accounting for approximately 75-80% of all malignant primary brain tumors in adults, with glioblastoma being the most aggressive and prevalent subtype [ 9 ] . In the United States, there are more than 24,000 new cases of malignant brain and other central nervous system tumors diagnosed annually, the majority of which are gliomas [ 9 ] . Patients with glioma suffer high mortality rates and limited long-term survival. Low-grade gliomas are generally slower growing and may be managed with surgical resection and adjuvant therapy; however, many progress to higher-grade malignancies over time [ 5 ] . High-grade gliomas exhibit rapid infiltration into surrounding brain tissue, resistance to treatment, and recurrence. Glioblastoma has a median survival of approximately 12-15 months following diagnosis and a 5-year survival rate below 10%. [ 5 , 9 ] . Gliomas all around the world impose a significant public health burden, as glioma patients often experience severe neurological deficits, including cognitive impairment, motor dysfunction, and seizures, which substantially reduce quality of life and functional independence [ 15 ] . Given these outcomes, accurate diagnosis, treatment planning, and longitudinal monitoring are critical for improving patient survival and quality of care, motivating the development of precise imaging-based tumor delineation methods. 1.1.2 Tumor Characterization and Segmentation Brain tumors, gliomas in this case, originate from glial cells that support nerve cells. This results in the uncontrolled division and growth of cells, leading to inflammation and death of brain cells. The NHS categorizes these brain tumors into four separate grades, with grades 1 and 2 classified as low-grade, non-cancerous, benign tumors, which are less likely to recur after treatment. On the contrary, grades 3 and 4 are categorized as high-grade, cancerous, malignant tumors that are more likely to spread throughout the brain and relapse after treatment. [ 6 ] Accurate representations of tumor subregions, including necrotic or non-enhancing tumor, peritumoral edema, and actively enhancing tumor, are essential for treatment planning, radiotherapy, and longitudinal monitoring, where multi-channel MRI volume scans are the standard for imaging modality. In the BraTS dataset, each patient has these four channels: T1-weighted (T1), contrast-enhanced T1 (T1Gd or T1c), T2-weighted (T2), and T2-FLAIR (FLAIR) volumes. Though, actual manual voxel-wise segmentation is time-consuming and prone to variability, requiring many hours to complete, for potentially biased results. By automating time-consuming tasks for radiologists, the use of AI in tumor segmentation drastically improves the efficiency of the treatments stated previously. Figure 1: All four channels of a sample BraTS-GLI patient and the corresponding manual segmentation overlaid on the T1Gd image. From left to right: T1, T1Gd, FLAIR, T2, and T1Gd with label map (red = NCR/NET, yellow = ED, green = ET). Figure created by Anthony Joon Hur using Python. Figure 2: Orthogonal axial, coronal, and sagittal FLAIR views with segmentation overlay for a representative BraTS-GLI case. Figure created by Anthony Joon Hur using Python. The BraTS challenge provides datasets and standardized evaluation metrics for automated tumor segmentation. Specifically, the 2023 adult glioma (GLI) challenge continues this by creating a competition to advance the field of automated brain tumor image analysis and segmentation by providing a benchmark for state-of-the-art algorithms with their datasets and results. 1.2 Literature Review 1.2.1 Current Research 1: CNN-based BraTS segmentation While earlier approaches relied on features that fed into random forests and/or support vector machines, since around 2014-2017, deep convolutional neural networks (CNNs) have become the dominant approach to BraTS segmentation. Specifically, these tumor segmentation methodologies based on 3D U-Net and are now standard, in which the four MRI modalities are concatenated as channels, and the network performs voxel-wise classification into background. In the BraTS challenge, these modalities were T1-weighted (T1), T1-weighted with gadolinium contrast (T1Gd), T2-weighted (T2), and T2 Fluid Attenuated Inversion Recovery (FLAIR). This MRI data is represented as volumetric data; typically, a 4D tensor shape of C x D x H x W (where C = 4 due to the number of modalities). The dominant architecture used for BraTS is 3D U-Net, an extension of the 2D U-Net proposed by Ronneberger et al. (2015) [ 8 ] , specifically adapted for volumetric segmentation by Çiçek et al. (2016) [ 7 ] . This architecture follows an encoder-decoder structure, in which the encoder path consists of repeated blocks of 3D convolutions, batch normalization, and non-linear activators, then max-pooling operations. This allows for the path to capture global context and semantic information, at the cost of spatial resolution. In order to recover this spatial resolution, the decoder up-samples or transposes convolutions, allowing for precise boundaries of the tumor. Additionally, feature maps from the encoder are concatenated with the corresponding layers in the decoder in a methodology called Skip connections. This allows the network to combine deep, semantic information with high-resolution surface details, mitigating the information loss caused by down-sampling. Input Volume ( 4\times D\times H\times W ) Encoder Block 1 Encoder Block 2 Bottleneck Decoder Block 2 Decoder Block 1 Output Segmentation Pool Pool Up Up Skip Connection (Concat) Skip Connection (Concat) Figure 3: Schematic representation of the 3D U-Net architecture used for BraTS segmentation. Dotted lines represent skip connections that concatenate encoder feature maps with decoder layers. Figure created by Anthony Joon Hur using LaTeX. 1.2.2 Current Research 2: nnU-Net More recent BraTS-winning solutions build on nnU-Net, a self-configuring U-Net framework that automatically adapts network topology and hyperparameters to the dataset fingerprint. The BraTS 2023 GLI winning solution uses nnU-Net as a base and then expands it with synthetic

Read the complete text